Rhumbline Advisers »

Akero Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 71k 23.35
2023-09-30 $3.6M 71k 50.58
2023-06-30 $2.9M 61k 46.69
2023-03-31 $2.1M 55k 38.25
2022-12-31 $2.8M 52k 54.80
2022-09-30 $1.4M 42k 34.05
2022-06-30 $374k 40k 9.45
2022-03-31 $375k 26k 14.19
2021-12-31 $543k 26k 21.17
2021-09-30 $586k 26k 22.37
2021-06-30 $621k 25k 24.81
2021-03-31 $396k 14k 29.01
2020-12-31 $372k 14k 25.83
2020-09-30 $404k 13k 30.77
2020-06-30 $285k 11k 24.90